PBAC Public Summary Documents - November 2008
Public summary documents relating to the November 2008 PBAC meeting
Page last updated: 19 March 2009
- Botulinum Toxin Type A Purified Neurotoxin Complex, lyophilised powder for I.M. injection 100 units vial, Botox®, November 2008
- Capecitabine, tablets 150 mg and 500 mg, Xeloda®, November
- Cetuximab, solution for I.V. infusion, 100 mg in 20 mL, 100 mg in 50 mL and 500 mg in 100 mL, Erbitux®, November 2008
- Desvenlafaxine succinate, tablet, (extended release), 50 mg and 100 mg (base), Pristiq®, November 2008
- Efalizumab, injection set containing 4 vials powder for injection 125 mg and 4 pre-filled syringes diluent 1.3 mL, Raptiva®, November 2008
- Exenatide, pre-filled injection pen, 5 micrograms per dose, 10 micrograms per dose, Byetta®, November 2008
- Hydromorphone hydrochloride, prolonged release tablets, 8 mg, 16 mg, 32 mg, 64 mg, Jurnista®, November 2008
- Ibandronic acid, tablet, 50 mg, Bondronat®, November 2008
- Lanthanum carbonate hydrate, chewable tablet, 500 mg, 750 mg and 1000 mg, Fosrenol®, Shire Australia Pty Ltd, November 2008
- Lenalidomide, capsules 5 mg, 10 mg, 15 mg and 25 mg, Revlimid®, November 2008
- Levetiracetam, tablet 250 mg, 500 mg and 1000 mg, oral solution 100 mg per mL, Keppra®, November 2008
- Maraviroc, tablet, 150 mg, 300 mg, Celsentri®, November 2008
- Modafinil, tablet, 100 mg, Modavigil®, November 2008
- Top of pageOseltamivir, capsules 30 mg, 45 mg and 75 mg, powder for oral suspension, 12 mg per mL, Tamiflu®, November 2008
- Oxybutynin, transdermal patches, 36 mg (releasing approximately 3.9 mg per 24 hours), Oxytrol®, November 2008
- Paclitaxel, powder for I.V. infusion (suspension), 100 mg, Abraxane®, November 2008
- Panitumumab, concentrated solution for infusion, 20 mg per mL, 5 mL, Vectibix®, November 2008
- Pegfilgrastim, injection, 6 mg in 0.6 mL single use pre-filled syringe, Neulasta®, November 2008
- Poly-L-lactic acid, powder for intradermal injection, 150 mg, Sculptra®, November 2008
- Pramipexole hydrochloride, tablet, 125 micrograms and 250 micrograms, Sifrol®, November 2008
- Tamsulosin hydrochloride, prolonged release tablet, 400 microgram, Flomaxtra®, November 2008
- Tenofovir Disoproxil Fumarate, tablet 300 mg, Viread®, November 2008
- Teriparatide, solution for injection, in a 3 mL cartridge contained in a pre-filled disposable delivery device (pen), 250 micrograms in 1 mL, Forteo®, November 2008
- Trastuzumab, powder for I.V. infusion, 150 mg, Herceptin®, November 2008
- Ziprasidone hydrochloride, capsules 20 mg, 40 mg, 60 mg and 80 mg, Zeldox®, November 2008
- Zoledronic acid, solution for I.V infusion, 5 mg in 100 mL, Aclasta®, November 2008
